Kazia Therapeutics (KZIA) Other Gross PP&E Adjustments (2016 - 2017)

Kazia Therapeutics (KZIA) posted Other Gross PP&E Adjustments of -$145832.0 for Q4 2017, down 581.97% on a QoQ basis from -$21384.0 in Q4 2016, and down 581.97% year-over-year from $30257.7 in Q4 2016.

Kazia Therapeutics (KZIA) has 2 years of Other Gross PP&E Adjustments data on file, last reported at -$145832.0 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -60,691.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -892,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -189.30 Mn
10 Kazia Therapeutics 1.55 Bn 1.55 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2017 -145,832.01
Dec 31, 2017 -145,832.01
Dec 31, 2016 -21,384.02
Dec 31, 2016 -21,384.02